Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2

Status

Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 87Breast Neoplasms 48Prostatic Neoplasms 43Squamous Cell Carcinoma of Head and Neck 34Lung Neoplasms 24Stomach Neoplasms 19Neoplasms 19Neoplasm Metastasis 16Head and Neck Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Urinary Bladder Neoplasms 13Carcinoma, Transitional Cell 11Triple Negative Breast Neoplasms 10Ovarian Neoplasms 8Endometrial Neoplasms 8Carcinoma, Squamous Cell 8Adenocarcinoma 8Non-Muscle Invasive Bladder Neoplasms 7HER2-positive Breast Cancer 7Prostatic Neoplasms, Castration-Resistant 6Melanoma 6Carcinoma 6Small Cell Lung Carcinoma 5Nasopharyngeal Carcinoma 5Esophageal Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4Fallopian Tube Neoplasms 4

Interventions

Injections 20Carboplatin 9pembrolizumab 8Bevacizumab 6Pemetrexed 5Paclitaxel 5Leucovorin 5Fluorouracil 5Docetaxel 5fludarabine 4Oxaliplatin 4Capecitabine 4sotorasib 3atezolizumab 3Drug Therapy 3Cyclophosphamide 3trifluridine tipiracil drug combination 2trametinib 2toripalimab 2spartalizumab 2palbociclib 2olaparib 2Panitumumab 2Nivolumab 2Immune Checkpoint Inhibitors 2Fulvestrant 2Etoposide 2Cisplatin 2Cetuximab 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Docetaxel × 1 year × Clear all
NCT05083481 2026-05-05

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1/2 Active not recruiting
226 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

CStone Pharmaceuticals

Phase 1/2 Recruiting
660 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05867420 2026-01-27

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

AskGene Pharma, Inc.

Phase 1/2 Recruiting
594 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

NCT05625412 2025-06-13

A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Completed
70 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡